InsiderMole.com - Free Insider Trading Analytics
Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...
It's often said that insider selling can be a hint that they know that their stock is about to underperform the market. Even though this is true in some cases, it's also true that insider selling is frequently simply behind financial reasons of the insiders and have no connection with the company's prospects. More ...
Insider trading is the buying or selling of shares of a company by someone who has access to material, non-public information on the company. Legal insider trading is when company insiders - officers, directors, employees and 10% owners - buy or sell shares in their company in accordance with securities laws and regulations. More ...
A ticker symbol or a trading symbol is an abbreviation used to identify a particular security listed on an exchange or otherwise publicly traded. More ...
Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...
Trade Like an Insider
Insiders (directors, board members, major shareholders) have access to non-public information about what’s happening in the company. Insider trading reveals whether insiders trust in their company and whether they are willing to bet their own money on further growth in the share price or, on the contrary, they sell because they believe that the price of the shares will fall.
Thousands of insider transactions are carried out a day. To give you a good grasp of it, we are gathering and clearly visualizing insider trading data. Our algorithm will help you find interesting investment opportunities.
Understand how insiders think and earn with them.
All in One Place
Watch the purchases and sales of individual insiders and purchases and sales within a company. Find out, whether only one or all board members buy or sell.
Our email watchdog will notify you for free about new insider trading for a person or a company. Get an instant overview of new events for persons or companies of your interest.
Create your profile and get an overview of insider trading in companies in your portfolio.
Watch insider trading within an industry. We are gathering insider trading information within an industry so you can get a view of the number and volume of transactions in individual industries.
In which company or industry insiders bought the most and where they sell the most? Which insider bought the most shares?
Top Companies that Buy in Last 4 Weeks
|WARNER MEDIA, LLC||$3,374,753,960,784,910|
|CENTRAL EUROPEAN MEDIA ENTERPRISES LTD||$3,374,753,910,729,750|
|DNP SELECT INCOME FUND INC||$2,480,715,657,741,580|
|AMERICAN INTERNATIONAL GROUP INC||$2,234,000,109,444,250|
|PRUDENTIAL FINANCIAL INC||$1,541,000,193,741,160|
|Tortoise Midstream Energy Fund, Inc.||$1,252,000,079,869,380|
|Voya Financial, Inc.||$592,000,031,821,028|
|ABERDEEN ASIA-PACIFIC INCOME FUND INC||$576,000,010,223,616|
|KUBOTA PHARMACEUTICAL HOLDINGS CO LTD||$308,418,962,311,650|
|TORTOISE ENERGY INFRASTRUCTURE CORP||$288,999,994,681,669|
Top Companies that Sell in Last 4 Weeks
|ADVANCED MICRO DEVICES INC||-$4,000,002,464,620,320|
|AMERICAN INTERNATIONAL GROUP INC||-$2,189,255,003,847,640|
|Kayne Anderson MLP/Midstream Investment Co||-$1,790,989,969,412,660|
|MGM Resorts International||-$400,001,097,849,472|
|KUBOTA PHARMACEUTICAL HOLDINGS CO LTD||-$308,056,263,713,258|
|TORTOISE ENERGY INFRASTRUCTURE CORP||-$161,935,198,781,466|
|CLEARBRIDGE AMERICAN ENERGY MLP FUND INC.||-$140,769,650,734,450|
|KAYNE ANDERSON MIDSTREAM/ENERGY FUND, INC.||-$88,268,993,657,703|
|HANSEN MEDICAL INC||-$42,105,426,732,608|
|ALPHA NETWORK ALLIANCE VENTURES INC.||-$26,438,107,398,144|
Top Insiders who Buy in Last 4 Weeks
|AOL TIME WARNER INC||$6,749,507,819,667,460|
|AMERICAN INTERNATIONAL GROUP INC||$4,468,000,217,631,230|
|PRUDENTIAL FINANCIAL INC||$3,082,000,147,677,180|
|Voya Financial, Inc.||$1,184,000,060,316,160|
|SBI Holdings, Inc.||$308,418,961,900,096|
|Goodman Anthony Brian||$275,854,231,956,629|
|AMERICAN GENERAL LIFE INSURANCE CO||$224,999,998,750,720|
|OPPENHEIMER FUNDS INC||$124,002,022,291,518|
Top Insiders who Sell in Last 4 Weeks
|AMERICAN INTERNATIONAL GROUP INC||-$4,378,509,992,247,810|
|Mubadala Investment Co PJSC||-$4,000,001,616,115,900|
|SBI Holdings, Inc.||-$308,056,260,870,144|
|FEINBERG LARRY N||-$42,105,405,702,144|
|Algodon Wines & Luxury Development Group, Inc.||-$22,787,649,437,696|
|Hudson Randolph Stewart||-$4,414,748,344,320|
What Our Customers Say?
Before I found InsiderMole.com I spent many hours a day reading hundreds of SEC Filing Forms. Today, I have all my information in one place and I’m getting email notifications about new information immediately. Thumbs up InsiderMole.com!
Good job! I used to use several other more expensive services. Now I can do with InsiderMole.com - I save money and mainly time! And time is what stock market is all about in the first place. InsiderMole.com has information about new trading immediately after it happens. That’s why I’m so satisfied with the service.
Latest Insider Trading Transactions
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Apr 19 2019||BDSI||BIODELIVERY SCIENC ...||ODONNELL FRANCIS E JR||Director||Option Exercise||A||4.96||22,500||111,600||22,500|
|Apr 19 2019||BDSI||BIODELIVERY SCIENC ...||ODONNELL FRANCIS E JR||Director||Option Exercise||A||0.00||45,000||0||45,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||Vishnoi Rohit||Director||Option Exercise||A||6.36||20,935||133,147||20,935|
|Apr 19 2019||INSY||Insys Therapeutics ...||Vishnoi Rohit||Director||Option Exercise||A||8.06||16,000||128,960||16,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||Vishnoi Rohit||Director||Grant||A||0.00||8,083||0||24,083||16 K to 24.1 K (+50.52 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Vishnoi Rohit||Director||Grant||A||0.00||6,000||0||16,000||10 K to 16 K (+60.00 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Long Andrew G||Chief Financial Off ...||Option Exercise||A||3.81||173,000||659,130||173,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||Long Andrew G||Chief Financial Off ...||Option Exercise||A||8.06||42,400||341,744||42,400|
|Apr 19 2019||INSY||Insys Therapeutics ...||Long Andrew G||Chief Financial Off ...||Grant||A||0.00||29,000||0||49,600||20.6 K to 49.6 K (+140.78 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Long Andrew G||Chief Financial Off ...||Grant||A||0.00||10,600||0||20,600||10 K to 20.6 K (+106.00 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Motahari Saeed||President & CEO||Option Exercise||A||3.81||282,152||1,074,999||282,152|
|Apr 19 2019||INSY||Insys Therapeutics ...||Motahari Saeed||President & CEO||Option Exercise||A||8.06||64,000||515,840||64,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||Motahari Saeed||President & CEO||Grant||A||0.00||59,206||0||130,192||71 K to 130.2 K (+83.41 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Motahari Saeed||President & CEO||Grant||A||0.00||16,000||0||70,986||55 K to 71 K (+29.10 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Nance Mark E||Chief Legal Officer ...||Option Exercise||A||3.81||70,000||266,700||70,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||Nance Mark E||Chief Legal Officer ...||Grant||A||0.00||10,000||0||25,000||15 K to 25 K (+66.67 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||Mahboob Vaseem||Director||Option Exercise||A||6.36||20,935||133,147||20,935|
|Apr 19 2019||INSY||Insys Therapeutics ...||Mahboob Vaseem||Director||Grant||A||0.00||8,083||0||14,083||6 K to 14.1 K (+134.72 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||BOHLEN ELIZABETH||Director||Option Exercise||A||6.36||20,935||133,147||20,935|
|Apr 19 2019||INSY||Insys Therapeutics ...||BOHLEN ELIZABETH||Director||Grant||A||0.00||8,083||0||14,083||6 K to 14.1 K (+134.72 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||LAPALME PIERRE||Director||Option Exercise||A||6.36||20,935||133,147||20,935|
|Apr 19 2019||INSY||Insys Therapeutics ...||LAPALME PIERRE||Director||Option Exercise||A||8.06||16,000||128,960||16,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||LAPALME PIERRE||Director||Grant||A||0.00||8,083||0||18,083||10 K to 18.1 K (+80.83 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||LAPALME PIERRE||Director||Grant||A||0.00||4,000||0||10,000||6 K to 10 K (+66.67 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||MEYER STEVEN J||Director||Option Exercise||A||6.36||20,935||133,147||20,935|
|Apr 19 2019||INSY||Insys Therapeutics ...||MEYER STEVEN J||Director||Option Exercise||A||8.06||16,000||128,960||16,000|
|Apr 19 2019||INSY||Insys Therapeutics ...||MEYER STEVEN J||Director||Grant||A||0.00||8,083||0||68,166||60.1 K to 68.2 K (+13.45 %)|
|Apr 19 2019||INSY||Insys Therapeutics ...||MEYER STEVEN J||Director||Grant||A||0.00||4,000||0||60,083||56.1 K to 60.1 K (+7.13 %)|